Dermatomyositis Completed Phase 0 Trials for Nifedipine (DB01115)

Also known as: Dermatomyositides / Dermatopolymyositis, unspecified

IndicationStatusPhase
DBCOND0002234 (Dermatomyositis)Completed0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03027674Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary RaynaudTreatment